Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00046709 · ClinicalTrials.gov registry record · Phase 1

Marijuana for Cancer Pain

A Phase 1 study, sponsored by Center for Medicinal Cannabis Research.

Terminated
Registry status
Phase 1
Development phase
16
Enrollment target

NCT00046709 is a Phase 1 study that was terminated before completion, run by Center for Medicinal Cannabis Research. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00046709, a Phase 1 study, was terminated before completion, sponsored by Center for Medicinal Cannabis Research.

TERMINATED
Registry status
Phase 1
Development phase
16 participants
Enrollment target

Study Summary

To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.

Interventions

  • DRUG Smoked Marijuana

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2002-09
Est. Completion 2004-10
Phase Phase 1

What the Registry Record Tells You About NCT00046709

The ClinicalTrials.gov registry entry for NCT00046709 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Medicinal Cannabis Research, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smoked Marijuana is the first listed.

NCT00046709 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00046709 about?

NCT00046709 is a clinical study titled "Marijuana for Cancer Pain". To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include n...

What is the current status of trial NCT00046709?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2002-09. Estimated completion is 2004-10.

What interventions are being tested in trial NCT00046709?

The interventions under investigation include: Smoked Marijuana (DRUG).

Who is sponsoring clinical trial NCT00046709?

This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.